Alex Arfaei trades his analyst's post for a new role as biotech VC; Sanofi vet heads to Vifor
Too often, Alex Arfaei arrived too late.
An analyst at BMO Capital Markets, he’d meet with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
